Meridian Bioscience, Inc. Q2 Profit Lags Street, Cuts FY View

April 16 (Reuters) - Medical diagnostic kit maker Meridian Bioscience Inc posted lower-than-expected quarterly earnings, hurt by weak diagnostic-product sales, and cut its fiscal 2009 outlook.

MORE ON THIS TOPIC